Scopus BioPharma Sends Letter Urging Stockholders to Vote
Company’s Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to...
United States Raphael Hofstein Joshuar Lamstein Davids Battleman Committee Contribution Scopus Biopharma Inc Nasdaq
Source: globenewswire.com